⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for primary tumor

Every month we try and update this database with for primary tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance MechanismsNCT05038358
Primary Tumor
Colon Tumor
18 Years - University Hospital, Grenoble
To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma TumorsNCT02410174
Primary Tumor
Renal Cell Carc...
Stereotactic Bo...
18 Years - Beth Israel Medical Center
ARQ 197 in Subjects With Metastatic Solid TumorsNCT00302172
Cancer
Tumor
ARQ 197
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Comparison of Gene Mutations in Matched Samples in Advanced Nonsquamous NSCLC Using NGSNCT02416726
Lung Cancer
Nextseq500 sequ...
18 Years - 80 YearsShanghai Chest Hospital
ARQ 197 in Subjects With Metastatic Solid TumorsNCT00302172
Cancer
Tumor
ARQ 197
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
ARQ 197 in Subjects With Metastatic Solid TumorsNCT00302172
Cancer
Tumor
ARQ 197
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
ARQ 197 in Subjects With Metastatic Solid TumorsNCT00302172
Cancer
Tumor
ARQ 197
18 Years - ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Identification of Predictive and Prognostic Markers for Lung Cancer With MetastasesNCT02301858
Lung Cancer
Primary Tumor
Metastases
Genome analysis...
18 Years - 90 YearsSykehuset i Vestfold HF
Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance MechanismsNCT05038358
Primary Tumor
Colon Tumor
18 Years - University Hospital, Grenoble
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: